Closed
9.48 0.74
24h
Min
9.3
Max
9.52
Income | -2.8M -16M |
---|---|
Sales | 1.9M 19M |
EPS | -0.05 |
Profit margin | -82.793 |
Employees | 97 |
EBITDA | 1.1M -7.6M |
Recommendations | Buy |
---|---|
12 Months Forecast | +30.48% upside |
Next Earnings | 12 maj 2025 |
---|
Market Cap | 3.6M 457M |
---|---|
Previous open | 8.74 |
Previous close | 9.48 |
By Trading Central
Confidence
Very Strong Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 12.33 USD 30.48%
High 15 USD
Low 10 USD
Based on 3 Wall Street analysts offering 12 month price targets forTheravance Biopharma Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$